Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
China Biologic Products Holdings, Inc.
Type
Public
Traded as NASDAQ: CBPO
Industry Biotechnology
Headquarters Beijing, China
Website www.chinabiologic.com

China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.

Investment goal date:
Dividends reinvested
China Biologic Products Holdings, Inc. CBPO report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-04
--
--
Q4 2017
2018-02-27
--
--
Q4 2017
2018-02-24
--
--
Q3 2017
2017-11-02
--
--
Q3 2017
2017-11-01
1.3800
1.1100
Q2 2017
2017-08-02
1.3500
1.0900
Q1 2017
2017-05-03
1.3200
1.0600
Q4 2016
2017-02-23
0.9500
0.6900
Q3 2016
2016-11-02
1.2200
1.0100
Q2 2016
2016-08-04
1.2600
1.1000
Q1 2016
2016-05-04
1.0900
0.9400
Q4 2015
2016-02-25
0.5900
0.5900
Q3 2015
2015-11-03
0.8200
0.8200
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ALLIANCEBERNSTEIN L.P.
555525
Artisan Partners Limited Partnership
395578
BAILLIE GIFFORD & CO
1395284
Bank of New York Mellon Corp
563527
BlackRock Fund Advisors
380241
BlackRock Inc.
1508096
BlackRock Institutional Trust Company, N.A.
306890
Capital Research Global Investors
3256848
Capital World Investors
1303418
FIL Ltd
878769
FMR LLC
1880549
HERMES INVESTMENT MANAGEMENT LTD
631224
Invesco Ltd.
1232413
Mirae Asset Global Investments Co., Ltd.
308282
WARBURG PINCUS & CO.
8344200
Major Shareholders
Name Relationship
Total Shares
Holding stocks